Thank you for attending THSNA 2026. The virtual meeting is now closed.
Use this page to browse all contributing authors.
Presentations for Angela Weyand
Clinical considerations in selection of newer hemophilia treatments |
Emicizumab for Severe von Willebrand Disease (VWD): the EmiVWD Study Enrollment 2026 |